drugset / Trial / NCT04499274
Ondansetron and Blood Coagulation
NaSingle-groupOpen-labelBasic science
Summary
Ondansetron may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of ondansetron. The investigators therefore will perform the present study to measure the effect of ondansestron on the blood coagulation pathway according to the drug concentration level using a thromboelastography test.
Timeline
- Start
- 2020-09-16
- Primary completion
- 2023-11-15
- Completion
- 2023-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ondansetron | Other / unclassified | 0 ml | — |
| Subject | Ondansetron | Other / unclassified | 0.0002 ml | — |
| Subject | Ondansetron | Other / unclassified | 0.002 ml | — |
| Subject | Ondansetron | Other / unclassified | 0.02 ml | — |